tretazicar has been researched along with 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Friedlos, F; Marais, R; Schepelmann, S; Spooner, R | 1 |
1 other study(ies) available for tretazicar and 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid
Article | Year |
---|---|
Methods to improve efficacy in suicide gene therapy approaches: targeting prodrug-activating enzymes carboxypeptidase G2 and nitroreductase to different subcellular compartments.
Topics: Antineoplastic Agents; Aziridines; Bystander Effect; Cell Survival; Female; gamma-Glutamyl Hydrolase; Genes, Transgenic, Suicide; Genetic Therapy; Glutamates; Humans; Nitrogen Mustard Compounds; Nitroreductases; Ovarian Neoplasms; Prodrugs; Subcellular Fractions; Transfection; Tumor Cells, Cultured | 2004 |